nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—SLC6A2—locus ceruleus—narcolepsy	0.271	0.309	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—narcolepsy	0.144	0.164	CbGeAlD
Reboxetine—HTR2C—brainstem—narcolepsy	0.0417	0.0475	CbGeAlD
Reboxetine—HTR2C—forebrain—narcolepsy	0.0403	0.0459	CbGeAlD
Reboxetine—SLC6A4—brainstem—narcolepsy	0.0395	0.0451	CbGeAlD
Reboxetine—SLC6A4—forebrain—narcolepsy	0.0382	0.0435	CbGeAlD
Reboxetine—SLC6A2—brainstem—narcolepsy	0.0348	0.0397	CbGeAlD
Reboxetine—SLC6A2—forebrain—narcolepsy	0.0336	0.0383	CbGeAlD
Reboxetine—HTR2C—medulla oblongata—narcolepsy	0.0291	0.0332	CbGeAlD
Reboxetine—HTR2C—midbrain—narcolepsy	0.0266	0.0303	CbGeAlD
Reboxetine—SLC6A4—midbrain—narcolepsy	0.0252	0.0287	CbGeAlD
Reboxetine—SLC6A2—medulla oblongata—narcolepsy	0.0243	0.0277	CbGeAlD
Reboxetine—CYP2D6—brainstem—narcolepsy	0.0191	0.0217	CbGeAlD
Reboxetine—CYP2D6—forebrain—narcolepsy	0.0184	0.021	CbGeAlD
Reboxetine—HTR2C—brain—narcolepsy	0.0167	0.019	CbGeAlD
Reboxetine—SLC6A4—brain—narcolepsy	0.0158	0.0181	CbGeAlD
Reboxetine—SLC6A2—brain—narcolepsy	0.0139	0.0159	CbGeAlD
Reboxetine—ABCB1—forebrain—narcolepsy	0.0132	0.0151	CbGeAlD
Reboxetine—ABCB1—medulla oblongata—narcolepsy	0.00956	0.0109	CbGeAlD
Reboxetine—ABCB1—midbrain—narcolepsy	0.00874	0.00996	CbGeAlD
Reboxetine—SLC6A4—Monoamine Transport—HRH3—narcolepsy	0.00827	0.0674	CbGpPWpGaD
Reboxetine—CYP2D6—brain—narcolepsy	0.00763	0.0087	CbGeAlD
Reboxetine—SLC6A2—Monoamine Transport—HRH3—narcolepsy	0.00712	0.058	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR2A—narcolepsy	0.00627	0.0511	CbGpPWpGaD
Reboxetine—ABCB1—brain—narcolepsy	0.00549	0.00626	CbGeAlD
Reboxetine—HTR2C—Amine ligand-binding receptors—HRH3—narcolepsy	0.0047	0.0383	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—narcolepsy	0.00416	0.0339	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—HCRTR2—narcolepsy	0.00349	0.0284	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—HCRTR1—narcolepsy	0.00349	0.0284	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2A—narcolepsy	0.00279	0.0227	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00256	0.0209	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00256	0.0209	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—P2RY11—narcolepsy	0.00247	0.0201	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00234	0.0191	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00229	0.0187	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00229	0.0187	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00221	0.018	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HCRT—narcolepsy	0.0021	0.0171	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00198	0.0161	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00198	0.0161	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00193	0.0157	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00191	0.0156	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00188	0.0153	CbGpPWpGaD
Reboxetine—SLC6A4—Monoamine Transport—TNF—narcolepsy	0.00177	0.0145	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0017	0.0138	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0017	0.0138	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00164	0.0133	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—TRH—narcolepsy	0.00159	0.013	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—NPS—narcolepsy	0.00158	0.0128	CbGpPWpGaD
Reboxetine—SLC6A2—Monoamine Transport—TNF—narcolepsy	0.00153	0.0124	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00142	0.0116	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00139	0.0113	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HCRTR1—narcolepsy	0.00129	0.0105	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HCRTR2—narcolepsy	0.00129	0.0105	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—P2RY11—narcolepsy	0.00125	0.0102	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00124	0.0101	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00116	0.00946	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—NPS—narcolepsy	0.00116	0.00943	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—TAC1—narcolepsy	0.00116	0.00943	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00108	0.0088	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HCRT—narcolepsy	0.00106	0.00864	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00106	0.0086	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00104	0.00844	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00104	0.00844	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00097	0.0079	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—PENK—narcolepsy	0.000945	0.0077	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000925	0.00754	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000907	0.00739	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TRH—narcolepsy	0.000803	0.00655	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000767	0.00625	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000767	0.00625	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00073	0.00594	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00073	0.00594	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.000705	0.00574	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.000705	0.00574	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.000696	0.00567	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00069	0.00562	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.000663	0.0054	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.000663	0.0054	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.00064	0.00521	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000623	0.00508	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.000599	0.00488	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.000584	0.00476	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.000584	0.00476	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.000544	0.00443	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000538	0.00439	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.000534	0.00435	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000499	0.00407	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.000485	0.00395	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000461	0.00376	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.000454	0.0037	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.000412	0.00336	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	0.000398	0.00324	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	0.000391	0.00319	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	0.000391	0.00319	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—P2RY11—narcolepsy	0.000378	0.00308	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HRH3—narcolepsy	0.000362	0.00295	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	0.000351	0.00286	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—NPS—narcolepsy	0.00033	0.00269	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	0.00033	0.00269	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000326	0.00266	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HCRT—narcolepsy	0.000321	0.00262	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TAC1—narcolepsy	0.0003	0.00244	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NPS—narcolepsy	0.0003	0.00244	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CHKB—narcolepsy	0.00029	0.00237	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PENK—narcolepsy	0.000286	0.00233	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000274	0.00223	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TRH—narcolepsy	0.000244	0.00198	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HRH3—narcolepsy	0.000214	0.00174	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000198	0.00162	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CPT1B—narcolepsy	0.000197	0.00161	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000186	0.00152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	0.00018	0.00147	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000179	0.00146	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TAC1—narcolepsy	0.000177	0.00144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPS—narcolepsy	0.000177	0.00144	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000161	0.00131	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000122	0.000991	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—narcolepsy	0.000106	0.000868	CbGpPWpGaD
